Fig. 9: Summary of study findings. | Nature Communications

Fig. 9: Summary of study findings.

From: Cell-free DNA from germline TP53 mutation carriers reflect cancer-like fragmentation patterns

Fig. 9

Classification of samples from TP53m-carriers and TP53-wildtype using cfDNA fragmentation features. Using these features and longitudinal sampling, cfDNA fragmentation features can also be used to create personalized cancer monitoring. Portions of Fig. 9 created with BioRender.com, released under a Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International license.

Back to article page